VVVVVVVV VEDA
Live / Allowed — Notice of allowance issued (as of 30 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98423612
- Mark type
- Design + words
- Filed
- 27 Feb 2024
- Published for opposition
- 06 May 2025
- Attorney of record
- Elizabeth Oliner
Goods and services
- Class 042 — Scientific and technological services: Platform as a service (PAAS) featuring computer software platforms for use in providing back-end automation features to assist in onboarding new clinical trial sites and healthcare providers for facilitating and enabling recruitment of participants for use in running, managing and analyzing clinical trials, namely enabling providers to create and scale clinical research capabilities and bring scientific advancements to patients that need them most; Platform as a service (PAAS) featuring computer software platforms for management and/or participation in clinical research in the nature of database creation and selecting configurable data collection methods with configurable options, configuring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows around patient communication, data entry, regulatory management and clinical trial operations use in facilitating and managing compliance and enabling preparation of new study trial sites for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring online non-downloadable software for engaging communitybased healthcare organizations and clinical trial sponsors for use in clinical research analytics, data capture forms,management, viewing data analytics, enabling site data capture; selecting configurable data collection methods with configurable options, configuring a participant- facing website to recruit and screen participants for eligibility; Platform as a service (PAAS) featuring computer software platforms for automating workflows around patient communication, data entry, regulatory management and clinical trial operations use in facilitating and managing compliance and enabling preparation of new study trial sites for use in bringing trained clinical research coordinators together with community managers to run clinical trials at scale; Providing a website featuring online non-downloadable software for engaging community- based healthcare organizations and clinical trial sponsors for use in clinical research analytics, data capture forms, electronic clinical outcome assessment, recruitment, and electronic consent; Providing information in the field of clinical research via a website; Providing scientific research information in the field of clinical trials; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; none of the foregoing comprised of or consisting of the provision of healthcare or telehealth services, scheduling healthcare or telehealth appointments, or allowing a patient to access personal healthcare information for the provision of healthcare or telehealth services.
Owner
- Veda Life Sciences, Inc., Frederick, MD, US
- Veda Life Sciences, Inc., Frederick, MD, US
Prosecution history
- 18 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 21 Jan 2026 — POST PUBLICATION AMENDMENT - ENTERED
- 13 Jan 2026 — ASSIGNED TO PETITION STAFF
- 30 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Nov 2025 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 08 Nov 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 28 May 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 06 May 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 May 2025 — PUBLISHED FOR OPPOSITION
- 30 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Mar 2025 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 24 Feb 2025 — NOTIFICATION OF FINAL REFUSAL EMAILED